Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Updated on: August 01,2024
0

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Updated on:August 01,2024
0
